Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjects

Journal of Allergy and Clinical Immunology
August 1, 1998
Cited by 137


Related Papers